Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amevive in overweight subjects with chronic plaque psoriasis
NCT00674063Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2003
- Primary completion
- Apr 2004
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 3 trial of alefacept in psoriasis, sponsored by Astellas Pharma. Started Jul 2003; status: completed.
02
Drugs
alefacept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00674063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674063.